The heterogenetic Forssman antigen is a glycosphingolipid, a ceramide pentasaccharide with the structure GalNAcal-s-3GalNAc,1-a3Galal---4Gal,1--.4Glc-.ceramide. Forssman-positive 
The appearance of incompatible blood group antigens foreign to the host may occur in some human tumors. In 1951 Levine et al. (1, 2) reported a case which suggested the synthesis of P and PI antigen in gastric cancer tissue of a rare p individual. A possible conversion of blood group 0 or B to an A-like antigen in human gastrointestinal tumor was suggested by two independent studies: (a) rabbit antiserum directed against a "human tumor glycolipid" fraction agglutinated blood group A erythrocytes more strongly than 0 or B erythrocytes although the glycolipid was prepared from the tumor of a patient of blood group 0 (ref. 3 ; see also Discussion in the present paper); and (b) Hakkinen (4) described the presence of A-like antigen in stomach cancers from patients whose blood group status was group 0 or B. The active fraction was described as a "sulfoglycoprotein."
In view of the extensive crossreaction between the Forssman and blood group A antigens (5, 6) , the A-like activity observed in those studies could have been due to the presence of a Forssman antigen. In fact, Kawanami (7) described the presence of Forssman glycolipid in one case of gastric cancer although the glycolipid composition of normal mucosa was not examined. Consequently, a thorough study has been undertaken using the surgical samples collected by one of the authors (S.M.W.) in Taiwan, where there is a high incidence of gastric cancer. The heterogenetic Forssman antigen (8) is a glycosphingolipid (9, 10) whose structure was identified as GalNAcal1-3GalNAc/ll-3Gala1-'"4Galfll1-'4Glc--ceramide (11, 12) . Forssman-positive animals, irrespective of species, are characterized by having a glycolipid of this structure (13) (14) (15) (16) ,* whereas Forssman-negative animals, including humans,t are considered to be unable to complete the carbohydrate structure, although they can synthesize the immediate precursor of the Forssman antigen, which has been identified as globoside (11) .
MATERIALS AND METHODS Tissues. Normal mucosa and cancer tissues from gastric and colonic mucosa were obtained from surgically extirpated specimens obtained in the National Taiwan University Hospital and its associated hospitals. All cases were diagnosed by histological examination, and the ABO blood group of patients was determined by standard procedures. Immediately after the specimens were extirpated, the tissues were cleaned by rinsing with saline and frozen in dry ice and stored at -70°. The samples were shipped to this institute in dry ice. After thawing, the tumor tissues and normal mucosa were carefully separated and weighed.
Preparation of Glycolipid Fractions, Including Ceramide Tetra-and Pentasaccharide. The total glycolipid fraction was prepared from the weighed tissue by the acetylation procedure ("procedure A") (19) , and was further separated into neutral glycolipids and gangliosides by DEAE-Sephadex A-25 according to the procedure of Yu and Ledeen (20 Fig. 1 ). Following this purification step, the Forssman glycolipid was deacetylated. An aliquot was degraded by a-N-acetylgalactosaminidase of pig liver (22) according to the procedure previously described (9) . Another portion was methylated (23) and identified by electron impact mass fragmentography (16) using a Finnigan 3300 mass spectrometer.
Immunological Analysis. Preliminary analysis of the total glycolipid fraction failed to demonstrate any Forssman reactivity. For this reason the immunological assays described below were run on the purified'ceramide tetra-and pentasaccharide fractions. Anti-Forssmnan and anti-globoside sera were prepared by injecting rabbits with mixtures of the purified glycolipid and bovine serum albumin emulsified in complete Freund's adjuvant as previously described (24) . Antibodies against the albumin were removed from the sera by passage through a bovine serum albumin-Sepharose column (25) . The titer of antiForssman serum for hemolysis of sheep erythrocytes was about 1:2500, while the titer of antigloboside serum for hemagglutination of trypsinized human erythrocytes was 1:128 to 1:
256.
The quantity of ceramide tetra-and pentasaccharide fractions to be tested was based on the dry weight of the tissue residue remaining after extraction of glycolipids with chloroform/methanol. The aliquots of fraction 5 and fraction 6 glycolipids corresponding to 50 mg of the dry tissue residue were mixed with 100 Ail of 5 mM sphingomyelin, 10 Ml of 50 mM chdlesterol, and 15 (27 (17, 29) . Much work is necessary to clearly define Forssman * The incidence of 5 cases of F+ against 16 cases of Fi isoantigen may be characteristic of Chinese in Taiwan, and the incidence in other racial groups may well be different. All tumors were histologically identified as adenocarcinoma; numbers for hemolysis inhibition and liposome lysis have the same meaning as in Table 1. expression in human tissue, but it could be possible that expression of Forssman is essentially of an "oncofetal" nature (30) in F-individuals; namely, its synthesis may be repressed during development and de-repressed in tumors. The repression of Forssman synthesis may not take place with development in some tissues, thus yielding F+ individuals. The "incomplete synthesis" model (31) can be applied to explain the deletion of (1977) . .; Proc. Natl. Acad. Sci. USA 74 (1977) 3027 as mentioned in the introduction could well be ascribable to the presence of Forssman antigen in tumors frbm 0, F--D-i, k individuals. The crossreactivity of blood group A and F6rssinan antigen is well known (5, 6); Forssman glycolipid is capable of inhibiting A-hemagglutination, and A-antigen inhibits hemolysis of sheep erythrocytes by anti-Forssman antibody (our own experience). However, further extensive study is necessary to identify the A-like (or "neo-A") antigen, occurring in clinical cases as was described by Hakkinen (4) . A possible relation of "A-like immunogenicity" displayed by "human tumor glycolipid" fraction to the Forssman Note Added in Proof. In contrast to the findings of Levine et al. (1, 2) , the studies described above on antigens [either the precursor, globoside (F-), or the final product, Forssman antigen (F+)] do not directly reflect the presence of corresponding human erythrocyte antigens. In an attempt to identify these two classes without resorting to biochemical procedures, P. Levine, M. Celano, W. W. Young, and S. Hakomori screened more than 100 normal sera (in a % dilution) for their capacity to hemolyze sheep erythrocytes in the presence of complement. In a separate experiment, 22 normal sera were tested for their capacity to lyse liposomes containing Forssman glycolipid in the presence of complement. Two classes were identified in both tests, i.e., lysers (about 70%) and nonlysers. Double-blind studies are being carrried out to determine if the lysers and nonlysers correspond with the F-and F+ populations, respectively. If so, the way will be open to carry out familial and racial studies on the two antigens by the immunological procedures outlined. Buchbinder (6) refers to two studies in 1928 and 1929 in which the same two classes were found upon screening normal human sera for their various capacities to hemolyze sheep erythrocytes. The costs of publication of this article were defrayed in part by the payment of page charges from funds made available to support the research which is the subject of the article. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
